CIRM 2020 Grantee Meeting

On September 14 and September 15 of 2020, CIRM hosted the 2020 Grantee Meeting with UC Irvine and UC San Diego.  Due to the nature of the coronavirus pandemic, the meeting was held virtually for the first time this year.  It brought together stem cell scientists and trainees that the institute is funding.  In addition to the complex science, we also heard from patients and patient advocates.  Click on the embedded links below to access videos to these presentations.

Day 1

Session 1: COVID-19 Clinical Trials

John Zaia, MD
Antibody Use for Treatment or Prevention of COVID-19

Michael Matthay, MD
Cellular Therapy for Acute Respiratory Failure – Mesenchymal Stromal Cells

Leonid Groysman, MD
United We Stand

Albert Wong, MD
Identifying the Peptides that Activate T-Cells in COVID-19 Patients

Session 2: Neurodegenerative Diseases (Alzheimer’s Disease, etc.)

Ralph Kern, MD, MHSc
NurOwn® (autologous MSC-NTF cells) in ALS-Phase 3 Clinical Trial Update

Jeanne Loring, PhD
Neuron Replacement Therapy for Parkinson’s disease

Leslie Thompson, PhD
Stem Cell Based Therapy for Huntington’s Disease

Session 3: Eye Diseases

Henry Klassen, MD, PhD
Retinal Progenitor Cells for Treatment of Retinitis Pigmentosa

Theodore Leng, MD, FACS
NeuBright, a Purified Allogeneic Cell Therapy Product for Treatment of Dry Age-related Macular Degeneration

Sophie Deng, MD, PhD
Limbal Stem Cell Therapy

Keynote Speaker: Dr. Nadine Burke Harris, California Surgeon General
Applying the Science of Toxic Stress to Transform Outcomes
Introduction by Maria Millan, MD

Session 4: Immune Disorders

Jennifer Puck, MD
Gene Therapy for Artemis Severe Combined Immunodeficiency (ART-SCID)

Don Kohn, MA, PhD
Hematopoietic Stem Cell Gene Therapy for Primary Immune Deficiencies

Mark Walters, MD
Gene correction in Sickle Cell Disease

Session 5: Cardiac Stem Cells

Deepak Srivastava, MD
Cellular Reprogramming Approaches for Heart Disease

Mark Mercola, PhD
Induced Pluripotent Stem Cell (iPSC)-derived Cardiomyocytes for Predicting and Removing Drug Cardiotoxicity

Debora Lieu, PhD
The Quest for Pacemaking Cardiomyocytes to Engineer Biopacemakers

Patient Advocate Speakers

Kristin MacDonald
Alysia Vaccaro
Pat Farrant

Session 6

Keith Yamamoto, PhD; Sergio Baranzini, PhD; Susan Gregurick, PhD; Oluwadamilola “Lola” Fayanju, MD; Robert Califf, MD; David Haussler, PhD
Knowledge Networks

View Day 2 Agenda >